Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1621-1640 of 2,360 trials

A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects

NCT03672604

This is a Phase 1, first-in-human study designed to assess the safety, tolerability, and pharmacokinetics of NLY01, a PEGylated form of exenatide, in healthy volunteers. NLY01 is being developed as a potential treatment for neurodegenerative disorders including Parkinson's disease. This study is intended to identify the appropriate dose-range for evaluation in Parkinson's disease patients.

Safety and Tolerability in Healthy Volunteers

Neuraly, Inc.96 participantsStarted Sep 2018

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

NCT01827046

A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).

Intracerebral Hemorrhage

Johns Hopkins University499 participantsStarted Dec 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +81 more locations

A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Rheumatoid Arthritis Trials in Other Cities

A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Soft Contacts Observation of Risk and Education (SCORE)

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

Other Conditions in San Antonio